24/10/2025
Exciting news from Igaku ✨
We’re officially partnering with Cellavie, a pioneer in regenerative medicine with over 15 years of clinical experience and global recognition.
Through this collaboration, Igaku now offers Human Umbilical Cord–Derived Mesenchymal Stem Cell (hUC-MSC) therapy — a safe, non-embryonic, and clinically tested cell type that supports recovery, hormonal balance, and long-term wellness.
💠 Treatment Options
• Premium Cells – Cellavie Active+
• Standard Cells - Cellavie Performance High Dose & Cellavie Harmony Standard Dose
• EMIT – Multicellular Immune Therapy
Certified for quality, safety, and trust — our stem cell products are Halal-certified, ensuring they meet international and Sharia-compliant standards.
⸻
👨⚕️ About Prof. Dr. Chin Sze Piaw .chin.sp
Co-founder of Cytopeutics Sdn Bhd and one of Asia’s most respected figures in stem cell research.
🏅 First Asian to receive the Global Major Award from the International Society of Cell & Gene Therapy (ISCT)
🎓 Visiting Professor, Economic Development Platform Committee, CPCCC, People’s Republic of China
🌍 Nominated for the UNESCO International Prize for Research in the Life Sciences
🏆 2023 Brand Icon Leadership Award recipient
🔬 Holds 3 US patents and 9 Malaysia patents related to mesenchymal stem cell treatments for heart disease, stroke, diabetes, osteoarthritis, GVHD, and cancer.
